Clinical Trials Sponsored by Trillium Therapeutics Inc.
Total 4 results
NCT03530683RecruitingConditions: Lymphoma; Myeloma
NCT02890368TerminatedTrial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesConditions: Solid Tumors; Mycosis Fungoides; Melanoma; Merkel-cell Carcinoma; Squamous Cell Carcinoma; Breast Carcinoma; Human Papillomavirus-Related Malignant Neoplasm; Soft Tissue Sarcoma
NCT02663518RecruitingConditions: Hematologic Malignancies; Solid Tumor
NCT01559961CompletedSafety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain SyndromeConditions: Interstitial Cystitis